Controlling Associate - Lausanne, Schweiz - Debiopharm

Debiopharm

Geprüftes Unternehmen

Lausanne, Schweiz

vor 1 Woche

Geschrieben von:

Lena Schneider

beBee Recruiter

Beschreibung

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to research in oncology and infectious diseases in order to improve patient outcomes and quality of life.

Our main activities include drug development, drug manufacturing and digital health investment. Debiopharm International SA aims to develop innovative therapies that target high unmet medical needs.

Our unique "development only" business model allows us to act as a bridge between disruptive discovery products and patient access in international markets.

We first identify high-potential compounds for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.

At Debiopharm you will be at the forefront of the fight against cancer and infectious diseases, and you will have the opportunity to work on new innovative medicines for patients.

Efficiency is our mode of action, saving lives our collective target.

For our Finance organization based at our Headquarters in Lausanne, we are looking for a

Controlling Associate

As a Controlling Associate you will be responsible for planning, coordination, and delivery of reporting & dashboards of the operating costs.

In addition, you will partner on projects with the IT team overseeing the financial performance and help reaching the company's digital transformation.

You will support the controlling service to ensure the smooth running of the financial activities.

Your responsibilities will be but not limited to:
Coordinate and consolidate the budgets/forecasts of the General & Administrative expenses in collaboration with business units, establish and present quarterly reports
Act as a finance business partner on investments in IT projects by providing total cost of ownership, calculation of payback & ROI
Responsible for the financial interactions & true up reconciliations for projects in cost sharing with pre-commercial alliances
Ensure rigorous control, budget/forecast and reporting of the contractors & consultants

Analyze commercial revenues:
develop and monitor performance indicators, quarterly reporting support, monitor compliance with contractual clauses

Participate in the closing activities, including analytical breakdowns, inter-company flows, verification of the consistency of accounting charges in collaboration with the accounting department.

Support the Controlling team with ad-hoc analysis as necessary
Work on digitalization & continuous process improvement of the activities

Requirements:

Bachelor or Master degree in Finance
At least 2-3 years of experience in Controlling within the industry or/and a first experience as Auditor for the industry within a BIG FOUR
Advanced skills with software related to controlling activities (ERP, BI, Excel...), knowledge of Jedox and Proconcept are a plus
Ability to link financial data to operations to ensure optimal support for decision making.
Team player & collaborative, you also work well independently
Solution oriented, you are looking to improve tools and processes
Detail-oriented, you are agile in setting up priorities

Benefits:

International, highly dynamic environment with a long term vision.
Cross-functional collaboration at the forefront of the most advanced scientific developments in oncology and anti-bacterial industry
Exposure to a wide variety of areas and functions within clinical development and the pharmaceutical industry
Participation in a company where innovation, people and entrepreneurship are the fundamental keys to success.
Proud to be an Equal-Pay certified, we ensure offering to all our employees the same opportunities

Submission of unsolicited resumes in advance of an agreement between the Human Resources Department and the external staffing agency or recruiter does not create any implied obligation on the part of Debiopharm.